Graham Wheeler

6PUBLICATIONS
15CO-AUTHORS
Radiation therapyHaematological tumoursMolecular targetsFormal methods for softwareCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2021
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.

Claire Roddie, Juliana Dias, Maeve A O'Reilly

|Jul 17, 2020
Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial.

Dean A Fennell, Sarah Danson, Penella J Woll

|Feb 18, 2020
A review of available software for adaptive clinical trial design.

Michael John Grayling, Graham Mark Wheeler

|Jan 20, 2019
How to design a dose-finding study using the continual reassessment method.

Graham M Wheeler, Adrian P Mander, Alun Bedding

|Mar 16, 2017
Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials.

Graham M Wheeler, Michael J Sweeting, Adrian P Mander

Pageof 1